Table 13.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1994 to 2003

Recipients with Heart-Lung Transplants

		Year of Transplant
		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Functioning Graft at Discharge		55	60	28	40	33	36	35	21	21	20
With Immunosuppression Info		53	60	25	38	31	35	35	21	21	19
Corticosteroids	Category Usage	100.0%	96.7%	88.0%	94.7%	90.3%	100.0%	100.0%	100.0%	100.0%	89.5%
	Steroids	100.0%	96.7%	88.0%	94.7%	90.3%	100.0%	100.0%	100.0%	100.0%	89.5%
Cyclosporine	Category Usage	92.5%	75.0%	68.0%	71.1%	71.0%	62.9%	80.0%	71.4%	61.9%	42.1%
	Cyclosporin	90.6%	73.3%	4.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	1.9%	1.7%	12.0%	7.9%	12.9%	17.1%	8.6%	9.5%	14.3%	5.3%
	Neoral	0.0%	0.0%	52.0%	63.2%	61.3%	51.4%	71.4%	61.9%	47.6%	21.1%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.9%	4.8%	4.8%	21.1%
Tacrolimus	Category Usage	1.9%	13.3%	20.0%	34.2%	32.3%	40.0%	31.4%	23.8%	42.9%	52.6%
	FK506	1.9%	13.3%	20.0%	34.2%	32.3%	40.0%	31.4%	23.8%	42.9%	52.6%
Antimetabolites	Category Usage	98.1%	95.0%	88.0%	94.7%	83.9%	82.9%	91.4%	95.2%	95.2%	78.9%
	Azathioprine	98.1%	95.0%	68.0%	76.3%	51.6%	37.1%	48.6%	42.9%	52.4%	47.4%
	Mycophenolate mofetil	0.0%	1.7%	24.0%	21.1%	38.7%	51.4%	51.4%	52.4%	47.6%	31.6%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	5.3%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	5.3%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.